EUROPA Study - EUROPA Symposium 2004


New Indication in CAD

EUROPA calendar
	ACC 2006 - Posters

	ESC 2005 - Symposium

	ESC 2005 - Oral sessions

	ESC 2005 - Posters

	AHA 2004 - Oral Session

	ESC 2004 - Hotline

	ESC 2004 - Symposium

	ACC 2004

	ESC 2003


EUROPA study

	EUROPA Results

	ESC 2003 Hotline - video

	Rationale for EUROPA

	Rationale for Perindopril

	Design & Organisation

	EUROPA investigators

	EUROPA collaborating centres

	EUROPA Recruitment


EUROPA Slide Set

	Rationale and Design

	Results

	Clinical Implications


EUROPA publications


PERSUADE

	PERSUADE Publications

	PERSUADE Results

	PERSUADE Fact Sheet


PERTINENT

	PERTINENT Results

	PERTINENT Fact Sheet


Background : Coronary Artery Disease

Home : Healthcare professionals : EUROPA Symposium 2004

EUROPA Symposium 2004



	THE EUROPA TRIAL^* PREVENTION OF MORBIDITY / MORTALITY IN CORONARY ARTERY DISEASE PATIENTS: BENEFITS BEYOND BLOOD PRESSURE Munich (Germany) Monday, August 30, 2004 (18.30 – 20.00) European Society of Cardiology Congress – Munich (Germany) Berlin / London Room Green zone * The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease

Chairpersons:
J.P. Bassand (France) – M. Tendera (Poland)

Introduction: M. Tendera (Poland)

EUROPA: revisiting the results
M. E. Bertrand (France)

EUROPA: effect of perindopril in stable coronary artery disease across the spectrum of risk
M. L. Simoons (Netherlands)

EUROPA: perindopril's benefits according to blood pressure ans endothelial function in coronary artery disease
W.J. Remme (Netherlands)

EUROPA: perindopril's action on the markers of thrombosis, inflammation and endothelial dysfunction in coronary artery disease
R. Ferrari (Italy)

EUROPA: Implementation in the management of coronary artery disease patients
K. M. Fox (UK)

Conclusion: J. P. Bassand (France)

This website is intended for an international audience. Drug related information may refer to unlicensed products or uses which may not be approved in your own country and you should therefore consult your local prescribing information.
This site is published and updated by the EUROPA study investigators. Site last updated March 21^st 2006